We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where ...

In a report released on October 4, Carter Gould from Barclays maintained a Buy rating on Merck & Company (MRK – Research Report), ...

The Animal Antibacterial and Antibiotics Market is being driven by several key factors. Rising livestock production and ...

Morgan Stanley analyst Terence Flynn has maintained their neutral stance on MRK stock, giving a Hold rating yesterday. Terence Flynn has given ...

Barclays analyst Carter Gould maintained a Buy rating on Merck & Company (MRK – Research Report) today and set a price target of ...

The July 30 update included Merck's acquisitions of EyeBio, and Elanco Animal Health's Aqua business, both of which Merck completed in early July. Merck indicated it would record a charge of ...

(RTTNews) - Merck Animal Health, a division of Merck & Co., Inc. (MRK), Tuesday announced the expansion of Nobivac NXT vaccine platform with the RNA-particle technology vaccine for the treatment ...

RAHWAY, N.J. - Merck Animal Health, a division of Merck & Co., Inc. (NYSE:MRK), has announced the release of a new vaccine, NOBIVAC NXT FeLV, to protect cats against feline leukemia virus (FeLV).

Merck & Co., Inc. develops pharmaceutical and vaccine products. It also offers healthcare solutions and vaccines addressing animal health. The company was founded in 1891 and is headquartered in ...